Rivaroxaban recanalized occlusive superior mesenteric vein thrombosis, but increased the risk of bleeding in a cirrhotic patient

Liver Int. 2017 Oct;37(10):1574-1575. doi: 10.1111/liv.13511. Epub 2017 Jul 21.

Authors

Xingshun Qi¹, Eric M Yoshida², Nahum Mendez-Sanchez³, Xiaozhong Guo¹

Affiliations

¹ Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, Liaoning Province, China.
² Division of Gastroenterology, Vancouver General Hospital, Vancouver, British Columbia, Canada.
³ Liver Research Unit Medica Sur Clinic & Foundation, Mexico City, Mexico.

PMID: 28675619
DOI: 10.1111/liv.13511

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Liver Cirrhosis
Mesenteric Ischemia
Mesenteric Veins*
Portal Vein
Rivaroxaban*
Thrombosis
Venous Thrombosis

Substances

Rivaroxaban